×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Vivanza Biosciences Limited | 15.11 | 0.43 | 15.01 | 0.01 | 10.9 | |
| ORTIN GLOBAL LIMITED | 0.34 | -1.07 | 0.34 | -0.13 | 9.94 | |
| Cian Healthcare Limited | NA | NA | NA | NA | 9.85 | 39.4 |
Vivanza Biosciences Limited, with Security Code 530057, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.3 | 1.0 | 4.8 | 6.0 | 4.8 | 3.8 | 3.3 | 2.2 | 0.4 | 1.5 |
| Expenses | 2.2 | 1.0 | 4.3 | 6.0 | 4.5 | 3.6 | 3.1 | 2.4 | 0.1 | 1.5 |
| Operating Profit | 0.1 | 0.0 | 0.5 | 0.0 | 0.4 | 0.2 | 0.3 | -0.1 | 0.3 | 0.1 |
| OPM % | 6.27% | 1.05% | 10.81% | 0.75% | 8.7% | 6.3% | 7.96% | -5.87% | 74.53% | 6.25% |
| Other Income | 0.0 | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.1 | 0.1 | 0.4 | 0.1 | 0.3 | 0.2 | 0.2 | -0.3 | 0.2 | 0.0 |
| Tax % | 0% | 0% | 0% | 187.3% | 0% | 0% | 0% | -41.9% | 0% | 0% |
| Net Profit | 0.1 | 0.1 | 0.4 | -0.1 | 0.3 | 0.2 | 0.2 | -0.4 | 0.2 | 0.0 |
| EPS in Rs | 0.14 | 0.37 | 1.04 | -0.14 | 0.01 | 0.05 | 0.01 | -0.09 | 0.06 | 0 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.4 | 5.9 | 8.2 | 9.2 | 7.6 | 6.6 | 4.4 | 2.4 | 3.0 | 1.5 |
| Expenses | 1.4 | 5.3 | 8.2 | 8.6 | 7.3 | 6.3 | 4.6 | 2.1 | 2.9 | 1.4 |
| Operating Profit | 0.0 | 0.6 | 0.0 | 0.6 | 0.3 | 0.3 | -0.1 | 0.4 | 0.1 | 0.1 |
| OPM % | -1.5% | 9.6% | -0% | 6.4% | 4.2% | 4.4% | -3.1% | 14.7% | 3.7% | 8.1% |
| Other Income | 0.3 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.2 | 0.5 | 0.0 | 0.5 | 0.3 | 0.2 | -0.3 | 0.3 | 0.0 | 0.0 |
| Tax % | 0% | 0% | 786.7% | 0% | 0% | 0% | -55.6% | 0% | 0% | 0% |
| Net Profit | 0.2 | 0.5 | -0.1 | 0.5 | 0.3 | 0.2 | -0.4 | 0.3 | 0.0 | 0.0 |
| EPS in Rs | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 45% |
| 3 Years: | 16% |
| TTM: | -72% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 22% |
| 3 Years: | 47% |
| TTM: | -115% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | -45% |
| 1 Year: | -65% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 60% |
| 3 Years: | 41% |
| TTM: | -64% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 27% |
| 3 Years: | 90% |
| TTM: | -109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | -45% |
| 1 Year: | -65% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|